Biosense Webster
Formerly Biosense
Diagnosis and Treatment of Cardiac Arrhythmias
Startup Acquired Health Tech & Life Sciences Est. 1993 Acquired
Total Raised
Undisclosed
Acquired
Last Round
Undisclosed
Team
2
500+ employees
Confidence
92/100
News
10
articles
Patents
1
About
Biosense Webster develops solutions designed to diagnose and treat cardiac arrhythmias. The company enables physicians to find and treat more types of disease by contributing directly to improving procedural methodologies and raising success rates. Biosense Websters CARTO Solutions provide navigational and mapping features to help physicians better treat theirpatients. Advanced 3D mapping modules integrate multiple datasets and images into one resource for highly detailed, real-time information. The company is a division of Johnson & Johnson Medical NV/SA.
Classification
Sector
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesMedical Treatment & Therapeutics
Core Technology
Simulation & ImagingUltrasound
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2CB2B
Tags
bioconvergencemedical-devicesreal-timemappingdiagnosticstherapeuticssurgerycatheterscardiology3d-technologyimagingcardiovascularhospitalsdoctorsheart-diseasesultrasoundtreatments
Funding & Events
Sep 1997
Exit $427M
News (10)
Oct 17, 2022 · www.news-medical.net
growth-positive
Biosense Webster launches HELIOSTAR™ in Europe, the first radiofrequency Balloon Ablation Catheter, enabling physicians to perform more efficient cardiac ablations
Customers
Sep 6, 2022 · www.jnj.com
Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology
growth-positive
Innovative Health lands another catheter reprocessing clearance - Medical Design and Outsourcing
CustomersPartners
May 16, 2019 · www.fiercebiotech.com
N/A
J&J's Biosense Webster launches cloud-based cardiac ablation data network
Nov 19, 2018 · www.businesswire.com
Biosense Webster Launches Report - The Burden of Atrial Fibrillation: Understanding the Impact of the New Millennium Epidemic Across Europe
Oct 1, 2018 · cardiacrhythmnews.com
growth-positive
Biosense Webster announces first patients enrolled in post-market approval study for its novel tag-index guided software
Customers
Jun 25, 2018 · globenewswire.com
growth-positive
Stereotaxis and Johnson & Johnson's Biosense Webster Extend Development Alliance and Supply Agreement
Partners
May 7, 2018 · www.prnewswire.com
growth-positive
Biosense Webster, Inc. Launches Sheath Designed To Reduce Radiation Exposure And Improve Ablation Procedure Efficiency
Customers
Jan 1, 2013 · www.globes.co.il
growth-positive
Israel attracts global healthcare giants
AcquisitionExpand
Sep 29, 1997 · www.globes.co.il
growth-positive
Johnson & Johnson Buys Biosense For $400 Mln in Shares
Acquisition
Details
Product Stage
Released
Employees
500+
Exact Count
3023
District
North District
Founded
1993
Registrar
511859134
Crunchbase
biosense-webster
Locations
HaTnufa St 4, Yokne'am Illit, Israel
Paseo Doce Estrellas, 5-7, Madrid, Spain
Staffans vg, Sollentuna, Sweden
Via del Mare, 56, Pomezia, Metropolitan City of Rome, Italy
Robert-Koch-Strae 1, Norderstedt, Germany
33 Technology Drive, Irvine, CA 92618, USA
2 Medical Road, Randjespark, Midrand, Johannesburg, South Africa
Airton Road, Tallaght, Dublin, Ireland
Gubelstrasse 34, Zug, Switzerland
Leonardo da Vincilaan 15, Diegem 1831 Machelen, Belgium
Estrada Consiglieri Pedroso 69, Portugal
Rue Camille Desmoulins, Issy-les-Moulineaux, France
Nine Mile Ride, Finchampstead, Wokingham, UK
Links
Website
LinkedIn
Twitter
Facebook
Admin
Last Update
Nov 18, 2024
Verified by
Jenny Sotnik-Talisman
Missing
markets, not claimed
Team (2)
Avi Shalgi
Director Business Development
Eti Godelnik
Director Finance, Compliance & Legal
Internal
Created by
Paz Eliav (paze@cet.ac.il)
Created
2015-02-12T00:00:00.000Z
Last editor
Yanina Wainscheinker (yanina.wainscheinker@sncentral.org)
Status
Acquired by Johnson & Johnson on Sep, 1997